Pharmacological Efficacy of Ginseng against Respiratory Tract Infections
Respiratory tract infections are underestimated, as they are mild and generally not incapacitating. In clinical medicine, however, these infections are considered a prevalent problem. By 2030, the third most comprehensive reason for death worldwide will be chronic obstructive pulmonary disease (COPD...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/13/4095 |
id |
doaj-19e490afe3d942918920369fc9e16e6f |
---|---|
record_format |
Article |
spelling |
doaj-19e490afe3d942918920369fc9e16e6f2021-07-15T15:43:04ZengMDPI AGMolecules1420-30492021-07-01264095409510.3390/molecules26134095Pharmacological Efficacy of Ginseng against Respiratory Tract InfectionsAbdulrhman Alsayari0Abdullatif Bin Muhsinah1Dalia Almaghaslah2Sivakumar Annadurai3Shadma Wahab4Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaRespiratory tract infections are underestimated, as they are mild and generally not incapacitating. In clinical medicine, however, these infections are considered a prevalent problem. By 2030, the third most comprehensive reason for death worldwide will be chronic obstructive pulmonary disease (COPD), according to the World Health Organization. The current arsenal of anti-inflammatory drugs shows little or no benefits against COPD. For thousands of years, herbal drugs have been used to cure numerous illnesses; they exhibit promising results and enhance physical performance. Ginseng is one such herbal medicine, known to alleviate pro-inflammatory chemokines and cytokines (IL-2, IL-4, IFN-γ, TNF-α, IL-5, IL-6, IL-8) formed by macrophages and epithelial cells. Furthermore, the mechanisms of action of ginsenoside are still not fully understood. Various clinical trials of ginseng have exhibited a reduction of repeated colds and the flu. In this review, ginseng’s structural features, the pathogenicity of microbial infections, and the immunomodulatory, antiviral, and anti-bacterial effects of ginseng were discussed. The focus was on the latest animal studies and human clinical trials that corroborate ginseng’s role as a therapy for treating respiratory tract infections. The article concluded with future directions and significant challenges. This review would be a valuable addition to the knowledge base for researchers in understanding the promising role of ginseng in treating respiratory tract infections. Further analysis needs to be re-focused on clinical trials to study ginseng’s efficacy and safety in treating pathogenic infections and in determining ginseng-drug interactions.https://www.mdpi.com/1420-3049/26/13/4095ginsengrespiratory tract infectionimmuno-modulatory effectscytokinesantiviral activityantibacterial activity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Abdulrhman Alsayari Abdullatif Bin Muhsinah Dalia Almaghaslah Sivakumar Annadurai Shadma Wahab |
spellingShingle |
Abdulrhman Alsayari Abdullatif Bin Muhsinah Dalia Almaghaslah Sivakumar Annadurai Shadma Wahab Pharmacological Efficacy of Ginseng against Respiratory Tract Infections Molecules ginseng respiratory tract infection immuno-modulatory effects cytokines antiviral activity antibacterial activity |
author_facet |
Abdulrhman Alsayari Abdullatif Bin Muhsinah Dalia Almaghaslah Sivakumar Annadurai Shadma Wahab |
author_sort |
Abdulrhman Alsayari |
title |
Pharmacological Efficacy of Ginseng against Respiratory Tract Infections |
title_short |
Pharmacological Efficacy of Ginseng against Respiratory Tract Infections |
title_full |
Pharmacological Efficacy of Ginseng against Respiratory Tract Infections |
title_fullStr |
Pharmacological Efficacy of Ginseng against Respiratory Tract Infections |
title_full_unstemmed |
Pharmacological Efficacy of Ginseng against Respiratory Tract Infections |
title_sort |
pharmacological efficacy of ginseng against respiratory tract infections |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2021-07-01 |
description |
Respiratory tract infections are underestimated, as they are mild and generally not incapacitating. In clinical medicine, however, these infections are considered a prevalent problem. By 2030, the third most comprehensive reason for death worldwide will be chronic obstructive pulmonary disease (COPD), according to the World Health Organization. The current arsenal of anti-inflammatory drugs shows little or no benefits against COPD. For thousands of years, herbal drugs have been used to cure numerous illnesses; they exhibit promising results and enhance physical performance. Ginseng is one such herbal medicine, known to alleviate pro-inflammatory chemokines and cytokines (IL-2, IL-4, IFN-γ, TNF-α, IL-5, IL-6, IL-8) formed by macrophages and epithelial cells. Furthermore, the mechanisms of action of ginsenoside are still not fully understood. Various clinical trials of ginseng have exhibited a reduction of repeated colds and the flu. In this review, ginseng’s structural features, the pathogenicity of microbial infections, and the immunomodulatory, antiviral, and anti-bacterial effects of ginseng were discussed. The focus was on the latest animal studies and human clinical trials that corroborate ginseng’s role as a therapy for treating respiratory tract infections. The article concluded with future directions and significant challenges. This review would be a valuable addition to the knowledge base for researchers in understanding the promising role of ginseng in treating respiratory tract infections. Further analysis needs to be re-focused on clinical trials to study ginseng’s efficacy and safety in treating pathogenic infections and in determining ginseng-drug interactions. |
topic |
ginseng respiratory tract infection immuno-modulatory effects cytokines antiviral activity antibacterial activity |
url |
https://www.mdpi.com/1420-3049/26/13/4095 |
work_keys_str_mv |
AT abdulrhmanalsayari pharmacologicalefficacyofginsengagainstrespiratorytractinfections AT abdullatifbinmuhsinah pharmacologicalefficacyofginsengagainstrespiratorytractinfections AT daliaalmaghaslah pharmacologicalefficacyofginsengagainstrespiratorytractinfections AT sivakumarannadurai pharmacologicalefficacyofginsengagainstrespiratorytractinfections AT shadmawahab pharmacologicalefficacyofginsengagainstrespiratorytractinfections |
_version_ |
1721298718860247040 |